TGFB1 and cancer: However, when produced at subcytotoxic, intermediate doses in cancer cells, superoxide can activate prosurvival and prometastatic intracellular signaling pathways, including the transforming growth factor-β (TGF-β) pathway, thereby converting a cancer cell in a metastatic progenitor cell [8].